Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA)
Historical Holders from Q2 2024 to Q3 2025
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Symbol
-
DRMA on Nasdaq
-
Shares outstanding
-
2,673,800
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
0
-
Total reported value
-
$0
-
Share change
-
-508,154
-
Value change
-
-$297,499
-
Avg sell value change
-
-0%
-
Number of holders
-
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
ARMISTICE CAPITAL, LLC
|
10%
|
0%
|
$820,109
|
+$607,264
|
1,065,076
|
+285%
|
Armistice Capital, LLC
|
31 Mar 2025
|
|
PROEHL GERALD T
|
13%
|
|
$619,155
|
|
804,098
|
|
PROEHL GERALD T
|
27 Mar 2025
|
|
INTRACOASTAL CAPITAL, LLC
|
5.5%
|
|
$102,941
|
+$86,603
|
147,059
|
+530%
|
Mitchell P. Kopin
|
24 Dec 2025
|
As of 30 Sep 2025,
Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) has
0
institutional shareholders
filing 13F forms.
They reported no common stock holdings, but disclosed options positions.
Institutional Holders of Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price (% of par)
|
Investors
|
|
2025 Q3
|
0
|
$0
|
-$297,499
|
|
|
|
0
|
|
2025 Q2
|
508,154
|
$297,499
|
-$7,049
|
|
|
58.5%
|
10
|
|
2025 Q1
|
518,513
|
$561,194
|
+$512,021
|
|
|
108%
|
8
|
|
2024 Q4
|
45,529
|
$61,465
|
+$51,415
|
|
|
135%
|
6
|
|
2024 Q3
|
6,444
|
$10,568
|
-$65,071
|
|
|
164%
|
4
|
|
2024 Q2
|
32,770
|
$78,254
|
+$78,254
|
|
|
238.99%
|
6
|